Control of vancomycin-resistant enterococci in the neonatal intensive care unit

被引:47
作者
Singh, N
Léger, MM
Campbell, J
Short, B
Campos, JM
机构
[1] George Washington Univ, Sch Med, Dept Pediat, Washington, DC 20010 USA
[2] George Washington Univ, Sch Publ Hlth, Natl Childrens Med Res Ctr, Washington, DC 20010 USA
[3] George Washington Univ, Sch Med, Dept Pathol & Microbiol, Washington, DC 20010 USA
[4] George Washington Univ, Sch Med, Dept Trop Med, Washington, DC 20010 USA
[5] George Washington Univ, Sch Med, Dept Hlth Care Sci, Washington, DC 20010 USA
[6] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Epidemiol, Washington, DC 20010 USA
[7] Childrens Natl Med Ctr, Sch Publ Hlth, Div Infect Dis, Hosp Epidemiol Program, Washington, DC 20010 USA
[8] Childrens Natl Med Ctr, Div Neonatol, Washington, DC 20010 USA
[9] Childrens Natl Med Ctr, Dept Lab Med, Washington, DC 20010 USA
关键词
D O I
10.1086/502595
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];
摘要
BACKGROUND AND OBJECTIVE: Multidrug-resistant organisms (MDROs), such as vancomycin-resistant enterococci (VRE), cause serious infections, especially among high-risk patients in NICUs. When VRE was introduced and transmitted in our NICU despite recommended infection control practices, we instituted active surveillance cultures to determine their efficacy in detecting and controlling spread of VRE among high-risk infants. METHODS: Active surveillance cultures, other infection control measures, and a mandatory in-service education module on preventing MDRO transmission were implemented. Cultures were performed on NICU admission and then weekly during their stay. Molecular DNA fingerprinting of VRE isolates facilitated targeting efforts to eliminate clonal spread of VRE. Repetitive sequence PCR (rep-PCR)-based DNA fingerprinting was used to compare isolates recovered from patients with VRE infection or colonization. Environmental VRE cultures were performed around VRE-colonized or -infected patients. DNA fingerprints were prepared from the products of rep-PCR amplification and analyzed using software to determine strain genetic relatedness. RESULTS: Active surveillance cultures identified 65 patients with VRE colonization or infection among 1,820 admitted to the NICU. Rep-PCR performed on 60 VRE isolates identified 3 clusters. Cluster 1 included isolates from 21 patients and 4 isolates from the environment of the index patient. Clusters 2 and 3 included isolates from 23 and 3 patients, respectively. Similarity coefficients among the members of each cluster were 95% or greater. CONCLUSIONS: Control of transmission of multi-clonal VRE strains was achieved. Active surveillance cultures, together with implementation of other infection control measures, combined with rep-PCR DNA fingerprinting were instrumental in controlling VRE transmission in our NICU.
引用
收藏
页码:646 / 649
页数:4
相关论文
共 36 条
[1]
Control of nosocomial acquisition of vancomycin-resistant Entcrococcus through active surveillance of hemodialysis patients [J].
Axon, RN ;
Engemann, JJ ;
Butcher, J ;
Lockamy, K ;
Kaye, KS .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2004, 25 (05) :436-438
[2]
Epidemiology and clinical consequences of vancomycin-resistant enterococci in liver transplant patients [J].
Bakir, M ;
Bova, JL ;
Newell, KA ;
Millis, JM ;
Buell, JF ;
Arnow, PM .
TRANSPLANTATION, 2001, 72 (06) :1032-1037
[3]
Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci [J].
Bonten, MJM ;
Hayden, MK ;
Nathan, C ;
vanVoorhis, J ;
Matushek, M ;
Slaughter, S ;
Rice, T ;
Weinstein, RA .
LANCET, 1996, 348 (9042) :1615-1619
[4]
Brooks S, 1998, INFECT CONT HOSP EP, V19, P333
[5]
Control of endemic vancomycin-resistant Enterococcus among inpatients at a University Hospital [J].
Calfee, DP ;
Giannetta, ET ;
Durbin, LJ ;
Germanson, TP ;
Farr, BM .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (03) :326-332
[6]
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004 [J].
Cardo, D ;
Horan, T ;
Andrus, M ;
Dembinski, M ;
Edwards, J ;
Peavy, G ;
Tolson, J ;
Wagner, D .
AMERICAN JOURNAL OF INFECTION CONTROL, 2004, 32 (08) :470-485
[7]
Curry V J, 2001, Crit Care Nurs Q, V24, P13
[8]
Monitoring antimicrobial use and resistance: Comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant enterococci [J].
Fridkin, SK ;
Lawton, R ;
Edwards, JR ;
Tenover, FC ;
McGowan, JE ;
Gaynes, RP .
EMERGING INFECTIOUS DISEASES, 2002, 8 (07) :702-707
[9]
The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units [J].
Fridkin, SK ;
Edwards, JR ;
Courval, JM ;
Hill, H ;
Tenover, FC ;
Lawton, R ;
Gaynes, RP ;
McGowan, JE .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (03) :175-183
[10]
VANCOMYCIN-RESISTANT ENTEROCOCCI COLONIZING THE INTESTINAL TRACTS OF HOSPITALIZED-PATIENTS [J].
GORDTS, B ;
VANLANDUYT, H ;
IEVEN, M ;
VANDAMME, P ;
GOOSSENS, H .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (11) :2842-2846